Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...

CLEVELAND, March 10, 2026 /PRNewswire/ -- Oncologists currently have limited tools to predict which lung cancer patients will benefit from immunotherapy. The publication of a multi-institutional study ...

Her German shepherd saved her life by detecting cancer in its earliest stage–and now an E-nose can detect tumors with AI chemical training.

Dr. Angel Nunez said the technology carries a significantly lower risk than traditional methods.

New research on 175,000 women—the largest NHS study to date—on the use of AI in breast cancer screening shows that AI ...

Age and smoking affect CT body composition in lung cancer screening cohorts. Discover how these markers may improve risk stratification.

Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.